The pharmaceutical business might seem like a very lucrative industry; but, in reality a lot of hard-work is pitched in by researchers to develop drugs. It takes more than a decade for researchers to develop a drug and release it in the market; however, before all this happens, a lot of efforts Chemistry Professor at the Northwestern University, Richard Silverman, said informed that for every 20,000 compounds evaluated in the industry, only ten are able to reach the stage for clinical trials. Following the trials and all the paperwork, only one drug is released in the market. Prof. Silverman was speaking at the Northwestern University campus located in downtown Chicago, on Thursday night. He informed that people thought, an array of drugs were being launched in the market; however, the current situation is in complete contradiction to popular belief. He informed that there are four separate stages before a drug is released in the market. The first basically involves an examination of dose levels and checking the safety of the medicine in people volunteering for the medicine. The second phase involved an evaluation of the effectiveness of the drug on the illness; while the third phase is considered to be the longest, it covers an astounding six years and thousands of patients are provided a drug during this time. It is currently under evaluation by the US food and Drug Administration. The FDA continues to check the drug in its fourth phase, after a proper evaluation the drug is released in the market. He concluded by saying that a drug on an average took 12 to 15 years to be released in the market if all goes according to plans.
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac...
-
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma...
-
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th...
-
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y...
-
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after...
-
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ...
-
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment